Lv5
1410 积分 2024-01-11 加入
聚乙二醇洛塞那肽临床应用专家共识
4天前
已完结
GLP-1受体激动剂临床应用专家指导意见
4天前
已完结
拓培非格司亭与硫培非格司亭用于淋巴瘤及多发性骨髓瘤患者自体外周血干细胞动员的疗效与安全性比较:一项前瞻性、多中心、随机对照研究
1个月前
已完结
拓培非格司亭 4mg 与硫培非格司亭 6mg 用于淋巴瘤/骨髓瘤自体外周血干细胞动员的疗效与安全性比较
1个月前
已关闭
Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory Waldenström macroglobulinemia: results from the Phase 1/2 BRUIN study
5个月前
已关闭
Luvometinib: First Approval
5个月前
已完结
Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015
7个月前
已完结
Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015
7个月前
已完结
Maintenance therapy for acute myeloid leukemia: sustaining the pursuit for sustained remission
7个月前
已完结
皖公网安备34019202002308
